DMAC
Diamedica Therapeutics
$9.82
+$1.13 (+13%)Oct 28, 2026
Key metrics
The numbers that frame DMAC today
- Market cap
- $529.55M
- ROIC
- -90.8%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $5.25
- 52wk High
- $10.42
Growth
Revenue and earnings trend for DMAC
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about DMAC
Is Diamedica Therapeutics a good buy?
Hold. Diamedica Therapeutics has excellent momentum, but poor quality makes the setup mixed. Growth looks excellent, which supports the long-term business case, but quality and momentum do not clear the bar together. We think Diamedica Therapeutics is selling at a high price.
What is the market capitalization of DMAC?
Diamedica Therapeutics's market capitalization is $529.55M.
What is the 52-week high for DMAC stock?
The 52-week high for Diamedica Therapeutics is $10.42. The current close of $9.82 is 5.7% below that high.
What is the 52-week low for DMAC stock?
The 52-week low for Diamedica Therapeutics is $5.25. The current close of $9.82 is 87.2% above that low.
Does DMAC stock pay dividends?
Diamedica Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for DMAC?
Diamedica Therapeutics's Debt / Equity ratio is 0.01.